19-48921157-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006184.6(NUCB1):c.1006G>T(p.Val336Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000187 in 1,606,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006184.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUCB1 | NM_006184.6 | c.1006G>T | p.Val336Leu | missense_variant | 11/13 | ENST00000405315.9 | NP_006175.2 | |
NUCB1 | XM_017026845.2 | c.1006G>T | p.Val336Leu | missense_variant | 11/13 | XP_016882334.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUCB1 | ENST00000405315.9 | c.1006G>T | p.Val336Leu | missense_variant | 11/13 | 1 | NM_006184.6 | ENSP00000385923 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247264Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134282
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1454258Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 722182
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.1006G>T (p.V336L) alteration is located in exon 11 (coding exon 10) of the NUCB1 gene. This alteration results from a G to T substitution at nucleotide position 1006, causing the valine (V) at amino acid position 336 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at